The webinar further explains our approach to these assessments, upcoming improvements for how we inform registrants about published assessments of regulatory needs for their substances, and how you can react in case your substance is addressed in a group assessment.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok